BUCKBINDER; Leonard

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUCKBINDER; Leonard.The latest application filed is for "acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease".

Company Profile

5.2.15

BUCKBINDER; Leonard - East Greenwich RI
Buckbinder; Leonard - Pawcatuck CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Acylated Active Agents And Methods Of Their Use For The Treatment Of Metabolic Disorders And Nonalcoholic Fatty Liver Disease App 20220296563 - CASEY, JR.; John Patrick ; et al.	2022-09-22
Acylated Active Agents And Methods Of Their Use For The Treatment Of Metabolic Disorders And Nonalcoholic Fatty Liver Disease App 20220296555 - CASEY, JR.; John Patrick ; et al.	2022-09-22
Acylated Active Agents And Methods Of Their Use For The Treatment Of Autoimmune Disorders App 20220110960 - TAYLOR; Steven John ; et al.	2022-04-14
Monomethyl Fumarate-carrier Conjugates And Methods Of Their Use App 20210299079 - CASEY, JR.; John Patrick ; et al.	2021-09-30
Acylated Active Agents And Methods Of Their Use For The Treatment Of Autoimmune Disorders App 20210283157 - TAYLOR; Steven John ; et al.	2021-09-16
Acylated active agents and methods of their use for the treatment of autoimmune disorders Grant 11,058,698 - Taylor , et al. July 13, 2	2021-07-13
Active Agents And Methods Of Their Use For The Treatment Of Metabolic Disorders And Nonalcoholic Fatty Liver Disease App 20210177877 - TAYLOR; Steven John ; et al.	2021-06-17
Acylated Catechin Polyphenols And Methods Of Their Use For The Treatment Of Cancer App 20210085640 - TAYLOR; Steven John ; et al.	2021-03-25
Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease Grant 10,953,027 - Taylor , et al. March 23, 2	2021-03-23
Active Agents And Methods Of Their Use For The Treatment Of Metabolic Disorders And Nonalcoholic Fatty Liver Disease App 20200197428 - TAYLOR; Steven John ; et al.	2020-06-25
Acylated Active Agents And Methods Of Their Use For The Treatment Of Autoimmune Disorders App 20200188418 - TAYLOR; Steven John ; et al.	2020-06-18
Methods for Augmenting Bone App 20090118316 - Olson; Lisa M. ; et al.	2009-05-07
Human cell assay to determine effect of sample compounds on Col2 enhancer expression App 20040241755 - Buckbinder, Leonard ; et al.	2004-12-02
Rapid assay to assess the potential for glucocorticoid analogs to promote the differentiation of human osteoblasts and predict bone safety App 20030224349 - Buckbinder, Leonard	2003-12-04
ADAMTS polypeptides, nucleic acids encoding them, and uses thereof App 20030166899 - Buckbinder, Leonard ; et al.	2003-09-04
ADAMTS polypeptides, nucleic acids encoding them, and uses thereof App 20020090373 - Buckbinder, Leonard ; et al.	2002-07-11
ADAMTS polypeptides, nucleic acids encoding them, and uses thereof App 20010049106 - Buckbinder, Leonard ; et al.	2001-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.